1.	Phase IV Randomized Pilot Study of Oxycodone Hydrochloride Versus Standard Three-Step Analgesic Therapy in Patients With Cancer-Related Pain Phase: Phase IV Type: Supportive care Status: Closed Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CRUK-ON/2003/1772, EU-20640, EUDRACT-2004-004235-66, NAPP-CRUK-ON/2003/1772, NCT00378937
2.	Phase III Chemotherapy with ARA-C/VCR/CTX/L-ASP/BLEO/PRED and VP-16 and CHOP (CTX/ADR/VCR/PRED) plus CNS Prophylaxis in Patients with High-Grade Lymphoma Who Are AIDS-Risk Group Members Phase: Phase III Type: Treatment Status: Completed Age: 18 to 60 Sponsor: Protocol IDs: LAC-USC-13NHL851, NCI-V85-0216
3.	T3AI-Pain After Breast Surgery Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: CDHA008, NCT00299039
4.	Phase I/II Study of High-Dose Acetaminophen With Carmustine in Patients With Metastatic Melanoma Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: MSKCC-97124, NCI-H98-0014, NCT00003346
5.	Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children Phase: Phase II Type: Treatment Status: Closed Age: 18 and under Sponsor: NCI Protocol IDs: POG-7831, MDAR-319
6.	Phase II Chemotherapy with DCF Alternating with IFN-alpha A in Patients with Hairy Cell Leukemia (Summary Last Modified 06/97) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: BRMP-8509, NCI-85-C-193, NCI-T85-0282N, T85-0282
7.	Phase II Master Protocol for the Evaluation of New Treatments in Patients with Primary Liver Cancer --- IFN-beta(ser) and Menogaril (Summary Last Modified 01/89) Phase: Phase II Type: Treatment Status: Completed Age: any age Sponsor: NCI Protocol IDs: EST-1286
8.	Phase II Chemotherapy with BLEO plus Chemopotentiation with Trifluoperazine in Patients with Malignant Brain Tumors Phase: Phase II Type: Treatment Status: Completed Age: 18 to 70 Sponsor: Protocol IDs: YALE-HIC-3839, NCI-V86-0093
9.	Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: CSTI571A2107, NCT00428909
10.	Double-Blind, Randomized, Multiple-Dose, Comparative Analgesic Efficacy and Safety Study of Ketorolac vs Acetaminophen plus Codeine, with a First-Dose Placebo Comparison, in Patients with Cancer Pain Phase: No phase specified Type: Supportive care Status: Closed Age: 18 and over Sponsor: Protocol IDs: NCOG-0N841, NCOG-0N-84-1